N-methyl-2-<(phenylmethyl)amino>acetamide | 111621-17-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-methyl-2-<(phenylmethyl)amino>acetamide
• 英文别名: 2-(Benzylamino)-N-methylacetamide
• CAS: 111621-17-1
• 化学式: C₁₀H₁₄N₂O
• mdl: MFCD11150642
• 分子量: 178.234
• InChiKey: DIVDOIBIQCYJML-UHFFFAOYSA-N

物化性质

• 沸点：
  352.0±25.0 °C(Predicted)
• 密度：
  1.048±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  41.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-methyl-2-<(phenylmethyl)amino>acetamide 、 N-<<1(S)-(cyclohexylmethyl)-2(R),3(S)-dihydroxy-5-methylhexyl>amino>-3(R)-(cyclopropylmethyl)-4-oxobutanoic acid 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 5.5h， 生成 (2R)-N'-benzyl-N-[(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl]-2-(cyclopropylmethyl)-N'-[2-(methylamino)-2-oxoethyl]butanediamide
  参考文献：
  名称：

  Discovery of non-peptidic P 2 –P 3 butanediamide renin inhibitors with high oral efficacy

  摘要：

  A new series of non-peptidic renin inhibitors having a 2-substituted butanediamide moiety at the P-2 and P-3 positions has been identified. The optimized inhibitors have IC50 values of 0.8 to 1.4 nM and 2.5 to 7.6 nM in plasma renin assays at pH 6.0 and 7.4, respectively. When evaluated in the normotensive cynomolgus monkey model, two of the most potent inhibitors were orally active at a dose as low as 3 mg/kg. These potent renin inhibitors are characterized by oral bioavailabilities of 40 and 89% in the cynomolgus monkey. Inhibitor 3z (BILA 2157 BS) was selected as candidate for pre-development. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)00265-x
• 作为产物：
  描述：

  N-[(1,1-二甲基乙氧基)羰基]-N-(苯基甲基)-甘氨酸 在 盐酸 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 生成 N-methyl-2-<(phenylmethyl)amino>acetamide
  参考文献：
  名称：

  Discovery of non-peptidic P 2 –P 3 butanediamide renin inhibitors with high oral efficacy

  摘要：

  A new series of non-peptidic renin inhibitors having a 2-substituted butanediamide moiety at the P-2 and P-3 positions has been identified. The optimized inhibitors have IC50 values of 0.8 to 1.4 nM and 2.5 to 7.6 nM in plasma renin assays at pH 6.0 and 7.4, respectively. When evaluated in the normotensive cynomolgus monkey model, two of the most potent inhibitors were orally active at a dose as low as 3 mg/kg. These potent renin inhibitors are characterized by oral bioavailabilities of 40 and 89% in the cynomolgus monkey. Inhibitor 3z (BILA 2157 BS) was selected as candidate for pre-development. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)00265-x

文献信息

• AMIDE DERIVATIVE
  申请人：Nakahira Hiroyuki

  公开号：US20100056497A1

  公开（公告）日：2010-03-04

  The present invention relates to a compound of the formula (I) being useful as a renin inhibitor, or a pharmaceutically acceptable salt thereof. wherein R 1a is a hydrogen atom, an optionally substituted C 1-6 alkyl, etc.; R 1b is an optionally substituted C 1-6 alkoxy, etc.; R 1c is a hydrogen atom, an optionally substituted C 1-6 alkoxy, etc.; R 2 is a hydrogen atom, an optionally substituted C 1-6 alkyl, etc.; R 3a , R 3b , R 3c and R 3d are independently the same or different, and each is a group of the formula: -A-B (in which A is a single bond, —(CH 2 ) s O—, —(CH 2 ) s N(R 4 )CO—, etc., B is a hydrogen atom, an optionally substituted C 1-6 alkyl, etc.), etc.; R 4 is a hydrogen atom, an optionally substituted C 1-6 alkyl, etc.; s is 0, etc.; and n is 1, etc.

  本发明涉及一种具有式(I)的化合物，其可用作肾素抑制剂，或其药学上可接受的盐。其中，R1a是氢原子，可选地取代的C1-6烷基等；R1b是可选地取代的C1-6烷氧基等；R1c是氢原子，可选地取代的C1-6烷氧基等；R2是氢原子，可选地取代的C1-6烷基等；R3a，R3b，R3c和R3d独立且相同或不同，每个是式：-A-B的基团（其中A是单键，-(CH2)sO-，-(CH2)sN(R4)CO-等，B是氢原子，可选地取代的C1-6烷基等）等；R4是氢原子，可选地取代的C1-6烷基等；s为0等；n为1等。
• Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
  申请人：Barrow James C.

  公开号：US20090111832A1

  公开（公告）日：2009-04-30

  The present invention is directed to imidazolidinone compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及咪唑啉酮化合物，其为beta-分泌酶酶的抑制剂，并且在治疗与beta-分泌酶酶有关的疾病，如阿尔茨海默病中有用。本发明还涉及包含这些化合物的制药组合物以及在治疗与beta-分泌酶酶有关的这些疾病中使用这些化合物和组合物的用途。
• 6-(1-Carbamoyl-1-hydroxymethyl)penicillanic-acid derivatives
  申请人：PFIZER INC.

  公开号：EP0220939A1

  公开（公告）日：1987-05-06

  6-(1-Carbamoyl-1-hydroxymethyl)penicillanic acid derivatives of the formula: wherein n is 0, 1 or 2; R is hydrogen, a radical group forming an ester hydrolyzable under physiological conditions, or an acyloxymethyl or 1-(acyloxy)ethyl radical derived from a conventional beta-lactam antibiotic; and R1 and R2 are taken separately and are each independently for example, hydrogen, (C1-C4)alkyl, (C5-C6)cycloalkyl, phenyl benzyl or one of said groups substituted by methyl, hydroxy, (Cl-C2)alkoxy, -COOR3, or -CONR3R4; or R1 and RZ are taken together with the nitrogen to which they are attached to form for example, a pyrrolidine, piperidine, perhydroazepine, morpholine 4-[formyl, (C1-C4)alkyl, phenyl benzyl, pyridyl or 2-hydroxyethyl]piperazine, indoline, isoindoline, 1,2,3,4-tetrahydroquinoline or 1,2,3,4-tetrahydroisoquinoline ring system, or one af said ring systems substituted by methyl, hydroxy, hydroxymethyl, carboxy, carbamoyl, -COOR3 or -CONR3R4. The compounds are useful as antibacterial agents and/or betalactamase inhibitors.

  式中的 6-(1-氨基甲酰基-1-羟甲基)青霉烷酸衍生物： 其中 n 是 0、1 或 2； R 是氢、在生理条件下可水解的形成酯的基团、或来自传统 beta-内酰胺类抗生素的酰氧基甲基或 1-（酰氧基）乙基；以及 R1 和 R2 分别独立地为氢、(C1-C4)烷基、(C5-C6)环烷基、苯基苄基或被甲基、羟基、(Cl-C2)烷氧基、-COOR3 或-CONR3R4 取代的上述基团之一；或 R1 和 RZ 与它们所连接的氮一起形成例如吡咯烷、哌啶、过氢氮杂卓、吗啉 4-[甲酰基、(C1-C4)烷基、苯基苄基、吡啶基或 2-羟乙基]哌嗪、吲哚啉、异吲哚啉、1,2,3,4-四氢喹啉或 1,2,3,4-四氢异喹啉环系，或其中一个被甲基、羟基、羟甲基、羧基、氨基甲酰基、-COOR3 或 -CONR3R4 取代的环系。 这些化合物可用作抗菌剂和/或β-内酰胺酶抑制剂。
• [EN] 6-(1-CARBAMOYL-1-HYDROXYMETHYL)PENICILLANIC ACID DERIVATIVES
  申请人：BARTH, Wayne, E.

  公开号：WO1990006928A1

  公开（公告）日：1990-06-28

  (EN) 6-(1-Carbamoyl-1-hydroxymethyl)penicillanic acid derivatives are useful as antibacterials and/or betalactamase inhibitors.(FR) Des dérivés d'acide 6-(1-carbamoyl-1-hydroxyméthyl)pénicillanique sont utiles comme agents antibactériens et/ou comme inhibiteurs de la bétalactamase.

  6-(1-羰酰甲基-1-羟甲基)青霉素衍生物作为抗生素和/或其他类药物用途十分有用。
• BARTH, WAYNE E.
  作者：BARTH, WAYNE E.

  DOI：——

  日期：——